We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+6.42%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$205M
AUM Growth
+$35.6M
(+21%)
Cap. Flow
-$35.2M
Cap. Flow
% of AUM
-17.19%
Top 10 Holdings %
Top 10 Hldgs %
38.54%
Holding
227
New
51
Increased
39
Reduced
41
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$2.06M |
| 2 |
Digital Turbine
APPS
|
+$1.87M |
| 3 |
Merck
MRK
|
+$1.39M |
| 4 |
Pfizer
PFE
|
+$1.11M |
| 5 |
Broadwind
BWEN
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DZSI
DZS Inc. Common Stock
DZSI
|
+$3.66M |
| 2 |
Aspen Aerogels
ASPN
|
+$2.95M |
| 3 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
+$2.56M |
| 4 |
Evolus
EOLS
|
+$1.72M |
| 5 |
indie Semiconductor
INDI
|
+$1.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.52% |
| 2 | Healthcare | 17.49% |
| 3 | Financials | 5.11% |
| 4 | Real Estate | 2.52% |
| 5 | Industrials | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
indie Semiconductor
INDI
$733M
| $6.42M | 3.13% |
608,167
-153,773
| -20% | -$1.37M |
|
2
Aviat Networks
AVNW
$262M
| $4.66M | 2.27% |
135,256
+1,250
| +0.9% | +$42.5K |
|
|
SCPH
3
DELISTED
scPharmaceuticals
SCPH
| $4.63M | 2.26% |
510,648
-116,705
| -19% | -$855K |
|
4
TELA Bio
TELA
$30.9M
| $4.36M | 2.13% |
409,649
-6,149
| -1% | -$67.8K |
|
5
Adtran
ADTN
$798M
| $4.21M | 2.06% |
265,692
-27,598
| -9% | -$479K |
|
|
TGAN
6
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $3.53M | 1.72% |
884,802
| – | – |
|
7
ANI Pharmaceuticals
ANIP
$1.77B
| $3.4M | 1.66% |
85,558
-2,459
| -3% | -$104K |
|
8
Silicom
SILC
$228M
| $2.81M | 1.37% |
74,896
+1,162
| +2% | +$47.2K |
|
9
Biodesix
BDSX
$228M
| $2.53M | 1.23% |
68,010
-6,888
| -9% | -$283K |
|
|
CMBM
10
DELISTED
Cambium Networks
CMBM
| $2.31M | 1.13% |
130,461
-13,038
| -9% | -$265K |
|
|
MRNS
11
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $2.27M | 1.11% |
+328,735
| New | +$2.06M |
|
|
CTIC
12
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2.17M | 1.06% |
516,589
+151,594
| +42% | +$787K |
|
13
Progressive
PGR
$124B
| $2.14M | 1.05% |
14,982
| – | – |
|
14
Hilton Grand Vacations
HGV
$3.84B
| $2.13M | 1.04% |
47,905
| – | – |
|
15
Franklin Covey
FC
$233M
| $2.12M | 1.04% |
55,174
+1,437
| +3% | +$66.3K |
|
|
16
Digital Turbine
APPS
$1.02B
| $2.05M | 1% |
166,130
+139,358
| +521% | +$1.87M |
|
17
Carvana
CVNA
$43.3B
| $1.95M | 0.95% |
997,980
-594,470
| -37% | -$1.03M |
|
18
OneMain Financial
OMF
$6.9B
| $1.8M | 0.88% |
48,433
-4,322
| -8% | -$174K |
|
19
Apollo Global Management
APO
$70.7B
| $1.74M | 0.85% |
27,503
+2,064
| +8% | +$138K |
|
|
CAMP
20
DELISTED
CalAmp Corp.
CAMP
| $1.73M | 0.84% |
20,940
-3,932
| -16% | -$384K |
|
|
PRTK
21
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.67M | 0.82% |
657,885
-364,590
| -36% | -$720K |
|
22
Capital One
COF
$124B
| $1.61M | 0.79% |
16,743
+4,375
| +35% | +$458K |
|
23
Everspin Technologies
MRAM
$354M
| $1.43M | 0.7% |
209,362
| – | – |
|
24
Raymond James Financial
RJF
$32.5B
| $1.37M | 0.67% |
14,720
-2,221
| -13% | -$235K |
|
|
25
Merck
MRK
$324B
| $1.37M | 0.67% |
+12,900
| New | +$1.39M |
|
Similar funds
VL
WTG
QCA
SP
OGC
PE
RL
AIIC
Worth Venture Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Worth Venture Partners held 227 positions worth $205M, up 21% from $169M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Worth Venture Partners withdrew a net $35.2M in Q1 2023, closing 39 positions and reducing 41 holdings. Its most notable exit was Aspen Aerogels, an estimated $2.95M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Worth Venture Partners opened a new position in Marinus Pharmaceuticals, Inc worth $2.27M.
- Worth Venture Partners's largest Q1 2023 buy was Marinus Pharmaceuticals, Inc: 328,735 shares worth $2.27M.
- Worth Venture Partners added most to Digital Turbine in Q1 2023, an estimated $1.87M increase.
- Worth Venture Partners's biggest Q1 2023 reduction was DZS Inc. Common Stock, cutting an estimated $3.66M.
- Worth Venture Partners fully exited Aspen Aerogels in Q1 2023, selling an estimated $2.95M.
- Worth Venture Partners's ten largest holdings make up 39% of its $205M portfolio in Q1 2023.
- Worth Venture Partners opened 51 new positions and closed 39 in Q1 2023.
- Worth Venture Partners's portfolio value rose 21% quarter-over-quarter to $205M.
Based on Worth Venture Partners's 13F filing for Q1 2023, filed 15 May 2023.